Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice

Nutr Res. 2012 Sep;32(9):684-93. doi: 10.1016/j.nutres.2012.08.003. Epub 2012 Sep 3.

Abstract

The aim of this study was to evaluate the effects of green tea extract (GTE) administration on vascular reactivity and atherosclerosis progression in low-density lipoprotein receptor knockout mice. We hypothesized that GTE intake may ameliorate atherosclerosis by improving endothelial dysfunction. Animals (n = 12 per group) were fed a hypercholesterolemic diet and received either water or GTE at a dose of 50, 100, or 300 mg/kg once a day by gavage (100 μL/10 g weight). After 4 weeks, atherosclerosis extension and vascular reactivity were evaluated in the aorta, and the levels of lipids, monocyte chemotactic protein-1 (MCP-1), and tumor necrosis factor α were measured in the plasma. Administration of GTE at a dose of 50 mg/kg significantly decreased the area of atherosclerotic lesions by 35%, improved the vascular reactivity in the isolated thoracic aorta, and lowered the plasma levels of both MCP-1 and triglycerides. Delivery of 100 mg/kg of GTE only promoted vasocontraction and vasorelaxation (P < .05), whereas a dose of 300 mg/kg was ineffective. Maximum contraction and relaxation negatively correlated with the lesion area (r = -0.755 and -0.767, respectively), whereas the plasma levels of MCP-1 and triglycerides positively correlated with plaque size (r = 0.549 and 0.421, respectively). In summary, our results supported the hypothesis that administration of GTE at low doses may contribute to a decrease in atherosclerosis progression by reversing endothelial dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / metabolism
  • Animals
  • Antioxidants / pharmacology*
  • Aorta / drug effects
  • Aorta / metabolism
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / pathology
  • Biomarkers / blood
  • Catechin / analogs & derivatives*
  • Catechin / pharmacology
  • Chemokine CCL2 / blood
  • Disease Models, Animal
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiopathology
  • Female
  • Inflammation / drug therapy
  • Inflammation / pathology
  • Lipoproteins, LDL / blood
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Plant Extracts / pharmacology*
  • Receptors, LDL / genetics
  • Tea / chemistry*
  • Triglycerides / blood
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Antioxidants
  • Biomarkers
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Lipoproteins, LDL
  • Plant Extracts
  • Receptors, LDL
  • Tea
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Catechin
  • epigallocatechin gallate
  • Alanine Transaminase